Pamicogrel (KBT3022) (Synonyms: KBT-3022) |
| Catalog No.GC32640 |
Le pamicogrel (KBT3022) (KBT3022) est un inhibiteur de la cyclooxygénase (COX).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 101001-34-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Pamicogrel (KBT3022) is a cyclooxygenase (COX) inhibitor.
Pamicogrel is a cyclooxygenase inhibitor with platelet anti-aggregatory properties which is under development by Kanebo for chronic arterial occlusion. Pamicogrel also has potential in both prophylaxis and treatment of ischemic brain injury[1].
[1]. Light P. Pamicogrel (Kanebo). IDrugs. 1999 Sep;2(9):938-42.
Average Rating: 5 (Based on Reviews and 35 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *